Correlation Between Karyopharm Therapeutics and Artiva Biotherapeutics,
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Artiva Biotherapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Artiva Biotherapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Artiva Biotherapeutics, Common, you can compare the effects of market volatilities on Karyopharm Therapeutics and Artiva Biotherapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Artiva Biotherapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Artiva Biotherapeutics,.
Diversification Opportunities for Karyopharm Therapeutics and Artiva Biotherapeutics,
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Karyopharm and Artiva is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Artiva Biotherapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artiva Biotherapeutics, and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Artiva Biotherapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artiva Biotherapeutics, has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Artiva Biotherapeutics, go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Artiva Biotherapeutics,
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to generate 1.32 times more return on investment than Artiva Biotherapeutics,. However, Karyopharm Therapeutics is 1.32 times more volatile than Artiva Biotherapeutics, Common. It trades about 0.05 of its potential returns per unit of risk. Artiva Biotherapeutics, Common is currently generating about -0.1 per unit of risk. If you would invest 70.00 in Karyopharm Therapeutics on October 14, 2024 and sell it today you would earn a total of 2.00 from holding Karyopharm Therapeutics or generate 2.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Karyopharm Therapeutics vs. Artiva Biotherapeutics, Common
Performance |
| Timeline |
| Karyopharm Therapeutics |
| Artiva Biotherapeutics, |
Karyopharm Therapeutics and Artiva Biotherapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Karyopharm Therapeutics and Artiva Biotherapeutics,
The main advantage of trading using opposite Karyopharm Therapeutics and Artiva Biotherapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Artiva Biotherapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artiva Biotherapeutics, will offset losses from the drop in Artiva Biotherapeutics,'s long position.| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
| Artiva Biotherapeutics, vs. Oatly Group AB | Artiva Biotherapeutics, vs. National Beverage Corp | Artiva Biotherapeutics, vs. SNDL Inc | Artiva Biotherapeutics, vs. Keurig Dr Pepper |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |